Ticker
ABMD

Price
-
Stock movement up
+- (%)
Company name
ABIOMED Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Markedsværdi
17.18B
Ent værdi
17.16B
Pris/omsætning
16.00
Pris/bog
11.16
Udbytte afkast
-
Udbyttevækst
-
Vekst år
-
FCF-udbetaling
-
Efterfølgende P/E
64.40
Fremtidig P/E
60.77
PEG
-
EPS-vekst
-
1 års afkast
8.18%
3 års afkast
30.28%
5 års afkast
14.86%
10 års afkast
39.53%
Senest opdateret: 2023-03-10
Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
22. december 2022

iO Charts is a Seeking Alpha partner

JNJ's agreed acquisition of ABMD at $380 per share came as a surprise to many healthcare focused investors. Click here to read our most recent analysis.
21. december 2022

iO Charts is a Seeking Alpha partner

UDBYTTE

ABMD betaler ikke udbytte

VÆRDIANSÆTTELSE

Værdiansættelsesforhold

Loading...
Værdiansættelsesforhold-data
Efterfølgende P/E64.40
Pris til OCF68.45
Pris til FCF112.19
Pris til EBITDA46.29
EV i forhold til EBITDA46.22

Værdiansættelse (salg/bogført værdi)

Loading...
Værdiansættelse (salg/bogført værdi)-data
Pris til omsætning16.00
Pris til egenkapital11.16
EV i forhold til salg15.97
Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
19. december 2022

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
8. december 2022

iO Charts is a Seeking Alpha partner

ØKONOMI

Pr. aktie

Loading...
Data pr. aktie
Aktuelt antal aktier45.09M
EPS (TTM)5.84
FCF pr. aktie (TTM)3.35

Resultatopgørelse

Loading...
Resultatopgørelse-data
Omsætning (TTM)1.07B
Bruttofortjeneste (TTM)873.51M
Driftsindkomst (TTM)253.61M
Nettoindkomst (TTM)266.76M
EPS (TTM)5.84
EPS (1 år frem)6.27

Marginer

Loading...
Marginer-data
Bruttomargin (TTM)81.32%
Driftsmargin (TTM)23.61%
Fortjenstmargin (TTM)24.84%

Balance

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
Kontanter182.34M
Nettotilgodehavender94.47M
Omsætningsaktiver i alt1.06B
Goodwill72.96M
Immaterielle aktiver50.13M
Ejendomme, anlæg og udstyr0.00
Sum aktiver1.70B
Kreditor35.07M
Kortfristet/nuværende langsigtet gæld0.00
Summen af kortfristede forpligtelser134.06M
Sum gæld156.76M
Aktionærernes egenkapital1.54B
Materielle nettoaktiver1.43B

Likviditet

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
Likviditet fra driften (TTM)250.98M
Investeringsudgifter (TTM)33.76M
Fri pengestrøm (TTM)153.14M
Udbetalt udbytte (TTM)0.00

Finansiel indkomst

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
Egenkapitalafkast17.32%
Afkast af aktiver15.72%
Afkast af investeret kapital17.32%
Kontant afkast af investeret kapital9.95%

INFORMATION OM AKTIER

Nedsidepotensial

Loading...
Nedsidepotensial-data
ABMDS&P500
Nuværende prisfald fra top notering-15.28%-19.84%
Højeste prisfald-94.31%-56.47%
Højeste efterår dato9 Oct 20029 Mar 2009
Gennemsnitlig fald fra toppen-47.58%-11.48%
Gennemsnitlig tid til nyt højdepunkt46 days13 days
Maks. tid til nyt højdepunkt3756 days1805 days
Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
1. november 2022

iO Charts is a Seeking Alpha partner

Abiomed, Inc. (NASDAQ:NASDAQ:ABMD) Q2 2023 Earnings Conference Call November 1, 2022 8:00 AM ETCompany ParticipantsJessica Moore - Vice President of...
1. november 2022

iO Charts is a Seeking Alpha partner

OPLYSNINGER OM VIRKSOMHEDEN
ABMD (ABIOMED Inc) company logo
Markedsværdi
17.18B
Markedsværdi kategori
Large-cap
Beskrivelse
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; Impella Connect, a cloud-based technology that enables secure and remote viewing of the automated impella controller for physicians and hospital staffs; and OXY-1 System, a portable external respiratory assistance device. In addition, the company is developing Impella ECP, a pump for blood flow of greater than three liters per minute; Impella XR Sheath, a sheath that expands and recoils allowing small bore access and closure with Impella heart pumps; Impella BTR, a percutaneous micro heart pump with integrated motors and sensors; and preCARDIA, a catheter-mounted superior vena cava therapy system designed to rapidly treat acutely decompensated heart failure. Abiomed, Inc. sells its products through direct sales and clinical support personnel in the Germany, France, United States, Japan, Europe, Canada, Latin America, the Asia-Pacific, and the Middle East. The company was founded in 1981 and is headquartered in Danvers, Massachusetts. As of December 22, 2022, Abiomed, Inc. operates as a subsidiary of Johnson & Johnson.
Personale
2003
Investor relationer
-
SEC-indsendelser
Adm. direktør
Michael R. Minogue
Land
USA
By
Danvers
Aktietype
Common stock
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
1. november 2022

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
1. november 2022

iO Charts is a Seeking Alpha partner

FORSTÅ FORRETNINGEN
Loading...
NYHEDER OM VIRKSOMHEDEN
Seeking AlphaPressemeddelelser
Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
1. november 2022
Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
1. november 2022
Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
31. oktober 2022
Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
20. oktober 2022
Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
17. oktober 2022
Abiomed is a compelling growth story in the medical technology space. See why we believe ABMD’s long-term investors can buy stock around current price.
28. september 2022
Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
16. september 2022
Abiomed, Inc. (NASDAQ:NASDAQ:ABMD) Q1 2023 Results Conference Call August 4, 2022 8:00 AM ETCompany ParticipantsNicole Nath - Manager, Investor...
4. august 2022
Get the latest news and real-time alerts from Abiomed, Inc. (ABMD) stock at Seeking Alpha.
4. august 2022
Abiomed reported robust earnings yesterday with double-digit growth from top-bottom. See why we remain unchanged on our previous rating of buy on ABMD stock.
4. august 2022
iO Charts is a Seeking Alpha partnerNæste side